Related Experiment Video
Updated: Dec 10, 2025

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Practical Approaches and Knowledge Gaps in the Care for Children With Leukodystrophies
Stephanie R Keller1, Eric J Mallack2, Jennifer P Rubin3
1Department of Pediatrics, Division of Pediatric Neurology, 1371Emory University/Children's Healthcare of Atlanta, Atlanta, GA, USA.
Insights
This study provides neurologic care guidelines for leukodystrophies, a group of rare genetic disorders. Recommendations focus on sleep, pain, seizures, and cognition, tailored to disease severity stages.
Area of Science:
- Neurology
- Genetics
- Pediatric Disorders
Background:
- Leukodystrophies are rare neurodegenerative genetic disorders affecting 1 in 7500 individuals.
- Existing neurologic care guidelines are limited, hindering physician and caregiver consensus.
- Patient advocacy meetings identified critical knowledge gaps in managing these conditions.
Purpose of the Study:
- To develop evidence-based guidelines for neurologic care in leukodystrophies.
- To address core domains prioritized by families: sleep, pain, seizures/epilepsy, and language/cognition.
- To establish a severity-based system for tailored patient management.
Main Methods:
- Literature review and synthesis of best practices from 2016-2018 patient advocacy meetings.
- Development of a disease severity classification system (presymptomatic, early, intermediate, advanced symptomatic).
- Identification of four key neurologic domains for focused recommendations.
Main Results:
- Established a framework for neurologic care based on defined stages of leukodystrophy severity.
- Prioritized recommendations across sleep, pain, seizures/epilepsy, and language/cognition domains.
- Highlighted the need for individualized care plans considering disease specifics and knowledge gaps.
Conclusions:
- Neurologic care for leukodystrophies requires tailored strategies aligned with disease severity stages.
- Standardized tools can aid treatment guidance without excessively burdening families.
- Addressing identified knowledge gaps is crucial for improving patient outcomes in leukodystrophies.
Abstract:
Leukodystrophies are a group of neurodegenerative genetic disorders that affect approximately 1 in 7500 individuals. Despite therapeutic progress in individual leukodystrophies, guidelines in neurologic care are sparse and consensus among physicians and caregivers remains a challenge. At patient advocacy meetings hosted by Hunter's Hope from 2016-2018, multidisciplinary experts and caregivers met to conduct a literature review, identify knowledge gaps and summarize best practices regarding neurologic care. Stages of severity in leukodystrophies guided recommendations to address different levels of need based on a newly defined system of disease severity. Four core neurologic domains prioritized by families were identified and became the focus of this guideline: sleep, pain, seizures/epilepsy, and language/cognition. Based on clinical severity, the following categories were used: presymptomatic, early symptomatic, intermediate symptomatic, and advanced symptomatic. Across the leukodystrophies, neurologic care should be tailored to stages of severity while accounting for unique aspects of every disease and multiple knowledge gaps present. Standardized tools and surveys can help guide treatment but should not overburden families.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Lysosomal Hydrolases
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children

